[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-353494-105":59,"doc-detail-353494-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","barnaculate-carcinoma-in-four-patients-verrucoid-squamous-cell-carcinoma-subtype-with-tert-and-hras-oncogenic-variants","Barnaculate Carcinoma in Four Patients - Verrucoid Squamous Cell Carcinoma Subtype with TERT and HRAS Oncogenic Variants","","Well-differentiated squamous cell carcinoma (SCC) in the oral cavity often shows limited pleomorphism, making subtype recognition difficult. Barnaculate carcinoma (BC) is a newly recognized distinct SCC subtype presenting obvious architectural abnormalities but lacking significant pleomorphism, so diagnosis can be challenging. Molecular analysis of six BC specimens from four patients identifies recurrent telomerase reverse transcriptase (TERT) promoter alterations and HRAS oncogenic variants, suggesting these variants as helpful diagnostic adjuncts.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/barnaculate-carcinoma-in-four-patients-verrucoid-squamous-cell-carcinoma-subtype-with-tert-and-hras-oncogenic-variants/353494/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/barnaculate-carcinoma-in-four-patients-verrucoid-squamous-cell-carcinoma-subtype-with-tert-and-hras-oncogenic-variants/353494.png","ImageObject",300,407,{"name":92,"@type":93},"Logic","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-14","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What makes barnaculate carcinoma (BC) difficult to diagnose histologically?","Question",{"text":112,"@type":113},"BC shows obvious architecture abnormalities but lacks significant pleomorphism, which complicates reaching the diagnosis in oral SCC samples.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which genetic alterations were recurrently detected in BC specimens?",{"text":117,"@type":113},"Molecular analysis demonstrated recurrent alterations in the TERT promoter region and the HRAS gene across specimens from four patients.",{"name":119,"@type":110,"acceptedAnswer":120},"How might TERT and HRAS oncogenic variants help clinicians?",{"text":121,"@type":113},"Identifying these oncogenic variants may serve as a useful adjunct when making the diagnostic determination of BC.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},353494,1790640781,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":39,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":46,"preview_page_count":19,"preview_urls":144},1099513958762,"https://ap-avatar.wpscdn.com/avatar/1000023916a998db790?x-image-process=image/resize,m_fixed,w_180,h_180&k=1784791008015729253","Head and Neck Pathology (2026) 20:6  \n[https://doi.org/10.1007/s12105-025-01870-3](https://doi.org/10.1007/s12105-025-01870-3)  \nRESEARCH  \nBarnaculate Carcinoma in Four Patients: Verrucoid Squamous Cell Carcinoma Subtype with TERT and HRAS Oncogenic Variants  \nYu Liang1 · Michelle Afkhami1 · Lester D. R. Thompson2 · Hanlin Gao3 · Ellie G. Maghami4 · Massimo D’Apuzzo1 · Sue Chang1 · Diana Bell1,5 · MihanTelatar1 · Thomas J. Gernon4 · Huiqing Wu1  \nReceived: 13 August 2025 / Accepted: 11 November 2025 © The Author(s) 2025  \nAbstract  \nWell-differentiated squamous cell carcinoma (SCC) in the oral cavity often has limited pleomorphism. Commonly seen in patients with proliferative verrucous leukoplakia, barnaculate carcinoma (BC) is a newly recognized, distinct subtype of well-differentiated SCC which presents with obvious architecture abnormalities but lacks significant pleomorphism. As such, reaching this diagnosis can be extremely challenging. In this study, molecular analysis of six BC specimens from four different patients demonstrated recurrent alterations in telomerase reverse transcriptase (TERT) promoter region and Harvey rat sarcoma virus (HRAS) gene. The identification of these oncogenic variants may be a useful adjunct to reaching the diagnosis.  \nKeywords Squamous cell carcinoma · Barnaculate carcinoma · Proliferative verrucous leukoplakia · TERT promoter mutation/oncogenic variant · HRAS mutation/oncogenic variant  \nIntroduction  \nSquamous cell carcinoma (SCC) is the most common typeof cancer affecting the lip and oral cavity. Oral SCC accounts for over 300,000 new annual cases world-wide, and 50% of these patients die from disease within five years [1, 2] . The common risk factors are excess alcohol consumption, tobacco use (smoking, snuff, and/or chewing), and betel nut chewing. Other risk factors include immune suppression  \nYu Liang and Michelle Afkhami have equally contributed to this work.  \n􀀍 Huiqing Wu [HWu@coh.org](HWu@coh.org)  \n1 Department of Pathology, City of Hope National Medical Center, 1500 E. Duarte Rd, Duarte, CA, USA  \n2 Head and Neck Pathology Consultations, Woodland Hills, CA, USA  \n3 Fulgent Genetics, El Monte, CA, USA  \n4 Department of Surgery, City of Hope National Medical Center, Duarte, CA, USA  \n5 Present address: Department of Pathology and Otolaryngology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA  \nand certain genetic tumor syndromes [3] . Surgeries with adequate resection margins, together with chemotherapy and radiation therapy, remain the main treatments. However, the overall prognosis is poor due to the late initial presentation and diagnosis at advanced tumor stage. Thus, early detection and accurate pathologic diagnosis play critical roles in the management of this cancer.  \nOral SCC is a group of morphologically, biologically, and clinically heterogenous and diverse malignant tumors. The histologic diagnosis of oral SCC and grading of precursor dysplastic lesions rely on the identification of pleomorphism, architectural disorganization, dysmaturation, abnormal keratinization, and often the presence of atypical mitoses. However, several subtypes of oral SCCs show distinct morphologic features. Well-differentiated SCC in the oral cavity often has limited pleomorphism with subtle architectural disorder. Verrucous carcinoma (VC) is well recognized as a unique carcinoma with well-differentiated exophytic and endophytic squamous epithelial proliferation creating a broad-pushing border of infiltration below the adjacent epithelium, church spire-type hyperkeratosis, parakeratinfilled crypts and clefts, broad rete, and without significant cytologic atypia [4, 5] . Biopsy of sufficient depth and size are required to accurately diagnose this subtype of SCC. A newly recognized distinct subtype of well-differentiated  \n1 3  \nSCC in patients with proliferative verrucous leukoplakia (PVL) has been referred to as barnaculate carcinoma (BC)  \n[5] . As proposed and described by T","cbCaijfSIcZoLUYe","https://ap.wps.com/l/cbCaijfSIcZoLUYe","pdf",1100740,"English","# Abstract\n# Introduction","[{\"question\":\"What makes barnaculate carcinoma (BC) difficult to diagnose histologically?\",\"answer\":\"BC shows obvious architecture abnormalities but lacks significant pleomorphism, which complicates reaching the diagnosis in oral SCC samples.\"},{\"question\":\"Which genetic alterations were recurrently detected in BC specimens?\",\"answer\":\"Molecular analysis demonstrated recurrent alterations in the TERT promoter region and the HRAS gene across specimens from four patients.\"},{\"question\":\"How might TERT and HRAS oncogenic variants help clinicians?\",\"answer\":\"Identifying these oncogenic variants may serve as a useful adjunct when making the diagnostic determination of BC.\"}]","Barnaculate Carcinoma in Four Patients - Verrucoid Squamous Cell Carcinoma Subtype with TERT and HRAS Oncogenic Variants | PDF",1790105767,[145,149,153,157],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d8368b5c98c94f30bdc3eb959a26f0d6.webp",983,1305,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/512fc598807f15d98b275066156290ff.webp",982,1304,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b5c998c3c5feb44a4cebbea335a1a08f.webp",981,1303,{"page_no":19,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c9a9e48c1a9c42e6a804c9980634c87e.webp",980,1301]